Simon L. Croft

Current scenario of drug development for leishmaniasis.

Simon L. Croft, Karin Seifert, Vanessa Yardley · PubMed · 2006 · 392 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Science +14

Structure–activity relationships of antileishmanial and antimalarial chalcones

Mei Liu, Prapon Wilairat, Simon L. Croft et al. · Bioorganic & Medicinal Chemistry · 2003 · 268 citations

Medicinal Chemistry, Biochemistry, Antiparasitic Agent +7

Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class

Richard K. Haynes, Burkhard Fugmann, Jörg Stetter et al. · Angewandte Chemie International Edition · 2006 · 257 citations

2- and 3-Substituted 1,4-Naphthoquinone Derivatives as Subversive Substrates of Trypanothione Reductase and Lipoamide Dehydrogenase from <i>Trypanosoma</i> <i>c</i><i>ruzi</i>:  Synthesis and Correlation between Redox Cycling Activities and in Vitro Cytotoxicity

Laurence Salmon-Chemin, Eric Buisine, Vanessa Yardley et al. · Journal of Medicinal Chemistry · 2001 · 256 citations · Full text

Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B

Patricia Escobar, Sangeeta Matu, Cláudia N. H. Marques et al. · Acta Tropica · 2002 · 231 citations

Parasitic Disease, Bioorganic Chemistry, Biochemistry +11